HKSecWiki新股资讯 2022年10月27日
10:20 PM EDT, 10/26/2022 (MT Newswires) -- LEPU ScienTech Medical Technology (Shanghai) (HKG:2291) launched its initial public offering in Hong Kong Thursday, seeking to raise up to HK$706.2 million ($90 million) from the deal.
美国东部时间2022年10月26日晚10：20(MT Newwires)--乐普科创医疗科技(上海)(HKG：2291)周四在香港进行首次公开募股，寻求通过这笔交易筹集至多7.062亿港元(合9000万美元)。
The medical device manufacturer is offering up to 22,455,000 shares, expected to be priced in the range of HK$29.15 to HK$31.45 per share, according to a same-day filing.
根据同日提交的一份文件，这家医疗器械制造商将发行至多22,455,000股票，预计发行价在每股29.15港元至31.45港元之间。
The company expects to determine the price of the IPO on Nov. 1 and disclose the results of the allocation on Nov. 7. The shares will begin trading on the stock exchange on Nov. 8.
该公司预计将于11月1日确定IPO价格，并于11月7日公布分配结果。股票将于11月8日开始在证券交易所交易。
The medical device manufacturer intends to use the proceeds for research and development within the next five years. The proceeds will also be used for the recruitment of personnel, sales and marketing activities, investments and acquisitions, expansion of production capacity, and for working capital and general corporate purposes.
这家医疗器械制造商打算在未来五年内将所得资金用于研发。所得款项还将用于招聘人员、销售和营销活动、投资和收购、扩大产能，以及用于营运资金和一般企业用途。
LEPU ScienTech Medical Technology attracted Harvest Great Bay Investment, Shanghai Lingang Economic Development Group Investment Management, and Jointown International Group as cornerstone investors.
乐普科创医疗科技吸引了嘉实大湾投资、上海临港经济发展集团投资管理、联城国际集团作为基石投资者。
China International Capital Corporation, CLSA, China Galaxy, Huatai Financial Holdings, and Valuable Capital are the joint bookrunners and lead managers of the IPO.
中金公司、里昂证券、中国银河、华泰证券金控和宝贵资本为此次IPO的联席账簿管理人和牵头经办人。
本页的译文内容由软件翻译。富途将竭力但却不能保证翻译内容之准确和可靠，亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
Was this helpful?
0 / 0
本文链接： https://www.hksecwiki.com/news/p20785552/
由HKSecWiki香港券商百科整理发布，香港证券开户请访问hksecwiki.com